Korppi Matti, Nuolivirta Kirsi, Lauhkonen Eero, Holster Annukka, Teräsjärvi Johanna, Vuononvirta Juho, Helminen Merja, He Qiushui, Koponen Petri
Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland.
Department of Pediatrics, Seinäjoki Central Hospital, Seinäjoki, Finland.
Pediatr Pulmonol. 2017 Jan;52(1):14-20. doi: 10.1002/ppul.23489. Epub 2016 May 26.
Variations in the genes that regulate innate immunity responses may be associated with susceptibility to asthma or atopy after early-life bronchiolitis. The aim of this study was to evaluate the association between four different polymorphisms of the IL-10 gene at rs1800871, rs1800872, rs1800890, and rs1800896, either alone or in combination, and post-bronchiolitis asthma or allergies at 5-7 years of age.
Data on single nucleotide polymorphisms (SNP) of IL-10 rs1800896 (-1082G/A), rs1800871 (-819C/T), rs1800872 (-592C/A), and IL-10 rs1800890 (-3575T/A) were available for 135 children. Polymorphisms and their associations with asthma and allergies were studied in 135 preschool-aged children who had been hospitalized for bronchiolitis at age 0-6 months. Their parents were interviewed to record the children's history with asthma and allergies from infancy to the present.
At 6.4 years (mean), asthma was present in 17 children (12.6%), while recurrent wheezing during the first 7 years of life was present in 39 (28.9%) children. Fifty-three (39.3%) study participants had current atopy (atopic eczema or allergic rhinitis). Eight (72%) of 11 children with the IL-10 rs1800896, IL-10 rs1800871, and IL-10 rs1800872 combination AA + CT + CA had current atopy (P = 0.02 vs. 38% in other genotype combinations). Twenty-three (56%) children with the IL-10 rs1800871C/T or IL-10 rs1800872C/A genotype had present atopy versus 34 (38%) with other IL-10 genotypes (P = 0.03). Between 2 years and 3 years of age, 27% of ATA haplotype carriers had asthma versus 13.7% of other haplotype carriers (P = 0.02).
IL-10 polymorphisms at rs1800871, rs1800872, rs1800890, and rs1800896 seem to be associated with elevated allergies and/or recurrent wheezing risk in later childhood, after early-life bronchiolitis. Pediatr Pulmonol. 2017;52:14-20. © 2016 Wiley Periodicals, Inc.
调节先天性免疫反应的基因变异可能与生命早期毛细支气管炎后患哮喘或特应性疾病的易感性相关。本研究的目的是评估白细胞介素-10(IL-10)基因在rs1800871、rs1800872、rs1800890和rs1800896位点的四种不同多态性单独或联合与5至7岁时毛细支气管炎后哮喘或过敏的相关性。
135名儿童有白细胞介素-10 rs1800896(-1082G/A)、rs1800871(-819C/T)、rs1800872(-592C/A)和白细胞介素-10 rs1800890(-3575T/A)的单核苷酸多态性(SNP)数据。对135名0至6个月时因毛细支气管炎住院的学龄前儿童的多态性及其与哮喘和过敏的相关性进行了研究。对他们的父母进行访谈,记录孩子从婴儿期到现在的哮喘和过敏病史。
平均6.4岁时,17名儿童(12.6%)患有哮喘,39名儿童(28.9%)在生命的前7年有反复喘息。53名(39.3%)研究参与者目前患有特应性疾病(特应性皮炎或过敏性鼻炎)。11名白细胞介素-10 rs1800896、白细胞介素-10 rs1800871和白细胞介素-10 rs1800872组合为AA + CT + CA的儿童中有8名(72%)目前患有特应性疾病(与其他基因型组合的38%相比,P = 0.02)。23名(56%)白细胞介素-10 rs1800871C/T或白细胞介素-10 rs1800872C/A基因型儿童患有特应性疾病,而其他白细胞介素-10基因型儿童中有34名(38%)患有特应性疾病(P = 0.03)。在2岁至3岁之间,ATA单倍型携带者中有27%患有哮喘,而其他单倍型携带者中有13.7%患有哮喘(P = 0.02)。
rs1800871、rs1800872、rs1800890和rs1800896位点的白细胞介素-10多态性似乎与生命早期毛细支气管炎后儿童期后期过敏和/或反复喘息风险升高有关。《儿科肺科杂志》。2017年;52卷:第14 - 20页。©2016威利期刊公司